Want to see GB:DXRX full AI Analyst Report?
Total Valuation
Diaceutics has a market cap or net worth of £123.43M. The enterprise value is 114.83M .
Market Cap£123.43M
Enterprise Value114.83M
Share Statistics
Diaceutics has 84,922,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding84,922,280
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Diaceutics’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.26%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.26%
Return on Capital Employed (ROCE)<0.01
Revenue Per Employee208.90K
Profits Per Employee527.17
Employee Count184
Asset Turnover0.77
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Diaceutics is 1327.3. Diaceutics’s PEG ratio is -11.04.
PE Ratio1327.3
PS Ratio2.82
PB Ratio2.67
Price to Fair Value2.67
Price to FCF75.98
Price to Operating Cash Flow95.03
PEG Ratio-11.04
Income Statement
In the last 12 months, Diaceutics had revenue of 38.44M and earned 97.00K in profits. Earnings per share was <0.01.
Revenue38.44M
Gross Profit26.12M
Operating Income266.00K
Pretax Income240.00K
Net Income97.00K
EBITDA6.08M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 1.30M and capital expenditures -71.00K, giving a free cash flow of 1.23M billion.
Operating Cash Flow1.30M
Free Cash Flow1.23M
Free Cash Flow per Share0.01
Dividends & Yields
Diaceutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change29.20%
50-Day Moving Average157.23
200-Day Moving Average154.85
Relative Strength Index (RSI)44.52
Average Volume (3m)79.63K
Important Dates
Diaceutics upcoming earnings date is Sep 29, 2026, Before Open (Confirmed).
Last Earnings DateMay 26, 2026
Next Earnings DateSep 29, 2026
Ex-Dividend Date―
Financial Position
Diaceutics as a current ratio of 3.43, with Debt / Equity ratio of 2.85%
Current Ratio3.43
Quick Ratio3.43
Debt to Market Cap0.00
Net Debt to EBITDA-1.02
Interest Coverage Ratio4.59
Taxes
In the past 12 months, Diaceutics has paid 143.00K in taxes.
Income Tax143.00K
Effective Tax Rate0.60
Enterprise Valuation
Diaceutics EV to EBITDA ratio is 16.79, with an EV/FCF ratio of 71.63.
EV to Sales2.66
EV to EBITDA16.79
EV to Free Cash Flow71.63
EV to Operating Cash Flow68.23
Balance Sheet
Diaceutics has £7.34M in cash and marketable securities with £1.15M in debt, giving a net cash position of £6.19M billion.
Cash & Marketable Securities£7.34M
Total Debt£1.15M
Net Cash£6.19M
Net Cash Per Share£0.07
Tangible Book Value Per Share£0.29
Margins
Gross margin is 73.80%, with operating margin of 0.69%, and net profit margin of 0.25%.
Gross Margin73.80%
Operating Margin0.69%
Pretax Margin0.62%
Net Profit Margin0.25%
EBITDA Margin15.81%
EBIT Margin0.69%
Analyst Forecast
The average price target for Diaceutics is £216.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target£216.00
Price Target Upside33.75% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast19.53%
EPS Growth Forecast―